Skip to main content
Clinical Trials/NL-OMON24286
NL-OMON24286
Not yet recruiting
Not Applicable

A combined, tailored pharmacist intervention with dose optimization of phosphate binding drugs to improve phosphate control in patients on dialysis.

Franciscus Gasthuis and Vlietland0 sites45 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Franciscus Gasthuis and Vlietland
Enrollment
45
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Franciscus Gasthuis and Vlietland

Eligibility Criteria

Inclusion Criteria

  • Both the mean serum phosphate level over the last 3 months and the last serum phosphate level are higher than 1\.5 mmol/L.
  • \-Prescription for 6 or more phosphate binder units daily
  • \- Age of 18 years or older
  • \-Medication dispensed by Poli\-apotheek Franciscus Gasthuis
  • \-Intermittent hemodialysis for at least 3 months preceding the inclusion date.
  • \-Hemodialysis during entire follow\-up
  • \-Sufficient language proficiency to comprehend instructions concerning study procedures, such as informed consent.

Exclusion Criteria

  • \-Patients residing in a nursing home
  • \-Cognitive impairment, resulting in failure to comprehend instructions concerning study procedures.

Outcomes

Primary Outcomes

Not specified

Similar Trials